These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 35339896)
1. Human tau accumulation promotes glycogen synthase kinase-3β acetylation and thus upregulates the kinase: A vicious cycle in Alzheimer neurodegeneration. Zhou Q; Li S; Li M; Ke D; Wang Q; Yang Y; Liu GP; Wang XC; Liu E; Wang JZ EBioMedicine; 2022 Apr; 78():103970. PubMed ID: 35339896 [TBL] [Abstract][Full Text] [Related]
2. Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease. Sharma N; Tramutola A; Lanzillotta C; Arena A; Blarzino C; Cassano T; Butterfield DA; Di Domenico F; Perluigi M; Barone E Neurobiol Dis; 2019 May; 125():176-189. PubMed ID: 30738142 [TBL] [Abstract][Full Text] [Related]
3. RNA Interference Silencing of Glycogen Synthase Kinase 3β Inhibites Tau Phosphorylation in Mice with Alzheimer Disease. Bian H; Bian W; Lin X; Ma Z; Chen W; Pu Y Neurochem Res; 2016 Sep; 41(9):2470-80. PubMed ID: 27255602 [TBL] [Abstract][Full Text] [Related]
4. Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer's disease models. Zhang H; Wang X; Xu P; Ji X; Chi T; Liu P; Zou L J Physiol Sci; 2020 Jun; 70(1):29. PubMed ID: 32517647 [TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link. Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110 [TBL] [Abstract][Full Text] [Related]
6. Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease. Jin N; Yin X; Yu D; Cao M; Gong CX; Iqbal K; Ding F; Gu X; Liu F Sci Rep; 2015 Feb; 5():8187. PubMed ID: 25641096 [TBL] [Abstract][Full Text] [Related]
7. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner. Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188 [TBL] [Abstract][Full Text] [Related]
8. TREM2 Inhibits Tau Hyperphosphorylation and Neuronal Apoptosis via the PI3K/Akt/GSK-3β Signaling Pathway In vivo and In vitro. Peng X; Guo H; Zhang X; Yang Z; Ruganzu JB; Yang Z; Wu X; Bi W; Ji S; Yang W Mol Neurobiol; 2023 May; 60(5):2470-2485. PubMed ID: 36662361 [TBL] [Abstract][Full Text] [Related]
9. miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3β in Alzheimer's disease. Li J; Chen W; Yi Y; Tong Q J Cell Biochem; 2019 Jun; 120(6):9936-9946. PubMed ID: 30556160 [TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease. Farr SA; Ripley JL; Sultana R; Zhang Z; Niehoff ML; Platt TL; Murphy MP; Morley JE; Kumar V; Butterfield DA Free Radic Biol Med; 2014 Feb; 67():387-95. PubMed ID: 24355211 [TBL] [Abstract][Full Text] [Related]
11. NPD1 Enhances Autophagy and Reduces Hyperphosphorylated Tau and Amyloid-β42 by Inhibiting GSK3β Activation in N2a/APP695swe Cells. Dai S; Zhou F; Sun J; Li Y J Alzheimers Dis; 2021; 84(2):869-881. PubMed ID: 34602482 [TBL] [Abstract][Full Text] [Related]
12. Stimulation of EphB2 attenuates tau phosphorylation through PI3K/Akt-mediated inactivation of glycogen synthase kinase-3β. Jiang J; Wang ZH; Qu M; Gao D; Liu XP; Zhu LQ; Wang JZ Sci Rep; 2015 Jun; 5():11765. PubMed ID: 26119563 [TBL] [Abstract][Full Text] [Related]
13. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells. Wu X; Kosaraju J; Tam KY Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686 [TBL] [Abstract][Full Text] [Related]
14. Effect of amyloid-β (Aβ) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK)-3β. Amin J; Paquet C; Baker A; Asuni AA; Love S; Holmes C; Hugon J; Nicoll JA; Boche D Neuropathol Appl Neurobiol; 2015 Jun; 41(4):445-57. PubMed ID: 25486988 [TBL] [Abstract][Full Text] [Related]
15. Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta. Liu F; Iqbal K; Grundke-Iqbal I; Gong CX FEBS Lett; 2002 Oct; 530(1-3):209-14. PubMed ID: 12387894 [TBL] [Abstract][Full Text] [Related]
16. Isoorientin, a GSK-3β inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice. Tan X; Liang Z; Li Y; Zhi Y; Yi L; Bai S; Forest KH; Nichols RA; Dong Y; Li QX Behav Brain Res; 2021 Feb; 398():112968. PubMed ID: 33069740 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease. Liu W; Liu X; Tian L; Gao Y; Liu W; Chen H; Jiang X; Xu Z; Ding H; Zhao Q Eur J Med Chem; 2021 Oct; 222():113554. PubMed ID: 34098466 [TBL] [Abstract][Full Text] [Related]
18. Could protein phosphatase 2A and glycogen synthase kinase-3 beta be targeted by natural compounds to ameliorate Alzheimer's pathologies? Manoharan SD; Abdul Hamid H; Md Hashim NF; Cheema MS; Chiroma SM; Mustapha M; Mehat MZ Brain Res; 2024 Apr; 1829():148793. PubMed ID: 38309553 [TBL] [Abstract][Full Text] [Related]
19. MiR-539-5p Decreases amyloid β-protein production, hyperphosphorylation of Tau and Memory Impairment by Regulating PI3K/Akt/GSK-3β Pathways in APP/PS1 Double Transgenic Mice. Jiang Y; Zhang Y; Su L Neurotox Res; 2020 Aug; 38(2):524-535. PubMed ID: 32415525 [TBL] [Abstract][Full Text] [Related]
20. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease. Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]